What are the major types of cancers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Major Types of Cancers

The major types of cancers include carcinomas, sarcomas, leukemias, lymphomas, and central nervous system cancers, which collectively account for approximately 95% of all cancer diagnoses. 1

Carcinomas

Carcinomas are the most common type of cancer, originating from epithelial cells that line internal and external body surfaces. They can be further categorized as:

  • Adenocarcinomas: Develop in glandular tissues

    • Breast carcinoma (most common in women ages 15-39) 1
    • Colorectal carcinoma
    • Prostate carcinoma
    • Lung adenocarcinoma
    • Thyroid carcinoma (second most common in women ages 15-39) 1
  • Squamous Cell Carcinomas: Arise from squamous epithelial cells

    • Head and neck carcinomas
    • Cervical carcinoma
    • Skin squamous cell carcinoma
    • Esophageal squamous cell carcinoma

Sarcomas

Sarcomas develop from connective tissues such as bone, cartilage, fat, muscle, and blood vessels:

  • Bone Sarcomas:

    • Osteosarcoma
    • Ewing sarcoma (outcomes worse for patients ≥18 years) 1
  • Soft Tissue Sarcomas:

    • Rhabdomyosarcoma (increasing age associated with poorer prognosis) 1
    • Liposarcoma
    • Fibrosarcoma

Hematologic Malignancies

Leukemias

Cancers that begin in blood-forming tissues:

  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML) (increasing age associated with poorer prognosis) 1
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myeloid Leukemia (CML)

Lymphomas

Cancers that begin in lymphatic system cells:

  • Hodgkin Lymphoma (HL): Has significantly better survival rates (94-97% 5-year survival) 2
  • Non-Hodgkin Lymphoma (NHL): More diverse group with variable survival rates (55-85% depending on subtype) 2
    • Burkitt and Burkitt-like lymphoma (increasing age associated with poorer prognosis) 1

Central Nervous System (CNS) Cancers

Cancers that start in brain or spinal cord tissues:

  • Gliomas (including glioblastoma, astrocytomas)
  • Meningiomas
  • Medulloblastomas (better survival in AYA patients compared to children) 1
  • Ependymomas 3

Germ Cell Tumors

Arise from reproductive cells:

  • Testicular cancer (most common cancer in men ages 15-39) 1
  • Ovarian germ cell tumors
  • Non-gonadal germ cell tumors

Neuroendocrine Tumors

Develop from cells that release hormones in response to nervous system signals:

  • Carcinoid tumors
  • Pancreatic neuroendocrine tumors
  • Pheochromocytomas

Epidemiology and Distribution

Cancer incidence varies significantly by age, sex, and geographic location:

  • Cancer is the leading cause of death among adolescents and young adults (AYAs), excluding homicide, suicide, or unintentional injury 1
  • Female AYA patients tend to have better 5-year relative survival compared to male AYA patients 1
  • The most frequently occurring cancers in high-income countries are lung, colorectal, female breast, cutaneous melanoma, and prostate 4

Important Considerations

Age-Specific Distribution

The frequency and incidence of cancer types varies dramatically across different age groups:

  • In women ages 15-39: Breast carcinoma (21.0 per 100,000), thyroid carcinoma (18.3), and cervical/uterine carcinoma (8.9) are most common 1
  • In men ages 15-39: Germ cell neoplasms (11.2 per 100,000), melanoma (5.0), and NHL (4.7) are most common 1

Cancer Syndromes

Some cancer types occur as part of inherited cancer syndromes:

  • Li-Fraumeni syndrome (p53 mutations): Predisposes to breast cancer, sarcomas, brain tumors, adrenocortical carcinoma, and leukemia 1, 5
  • BRCA-related hereditary breast/ovarian cancer 1
  • Fanconi anemia 1

Cancers of Unknown Primary

Approximately 3-5% of all malignancies present as metastases without an identifiable primary site 1. These are categorized pathologically as:

  • Well and moderately differentiated adenocarcinomas
  • Poorly differentiated carcinomas
  • Squamous cell carcinomas
  • Undifferentiated neoplasms
  • Carcinomas with neuroendocrine differentiation 1

Modifiable Risk Factors

The most important causes of cancer include:

  • Tobacco use (primarily cigarette use)
  • Excess alcohol consumption
  • Obesity
  • Lack of physical activity
  • Diets low in fruits and vegetables
  • Infectious agents
  • Sun exposure 4

Understanding these major cancer types and their characteristics is essential for proper diagnosis, treatment planning, and improving outcomes for patients with cancer.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lymphoma Survival Rates and Treatment Outcomes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

Journal of the National Comprehensive Cancer Network : JNCCN, 2023

Research

Epidemiology of Cancer.

Clinical chemistry, 2024

Research

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.